Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

BERLIN & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 11, 2025-

Bayer, Broad Institute Extend Agreement to Develop New Cardiovascular Therapies

Focus on joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Current efforts focused on treatment options for specific forms of cardiovascular disease such as dilated cardiomyopathy

Broad Institute and Bayer extend their cardiovascular alliance

Broad Institute and Bayer extend their cardiovascular alliance By Leah Eisenstadt June 11, 2025 Breadcrumb Home Broad Institute and Bayer extend their cardiovascular alliance Partnership will continue with renewed focus on developing new cardiovascular therapies. By Broad Communications June 11, 2025 Related news Broad Institute and Bayer expand cardiovascular alliance Broad Institute of MIT and Harvard and Bayer Healthcare expand their…